NCT00215605 Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT00212862 Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia Status COMPLETED Phase N/A
NCT00210132 Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery Status COMPLETED Phase PHASE2
NCT00207181 The Development and Testing of an Electronic Tool to Measure Physical Activity in Domestic Settings Status COMPLETED Phase N/A
NCT00206609 The Role of Oxygen in the Management of Dyspnoea in Advanced Cancer Status COMPLETED Phase PHASE3
NCT00201539 Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients Status COMPLETED Phase PHASE3
NCT00200096 Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial Status COMPLETED Phase PHASE3
NCT00199836 A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. Status COMPLETED Phase PHASE1
NCT00199602 Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients Status COMPLETED Phase PHASE3
NCT00198276 Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer Status COMPLETED Phase PHASE4
NCT00193583 Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00193570 Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00184496 Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study Status COMPLETED Phase PHASE3
NCT00183742 Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere) Status COMPLETED Phase PHASE1
NCT00181012 Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics Status UNKNOWN Phase PHASE3
NCT00180869 Unmodified Versus Leuko-reduced Allogeneic Red Blood Cells Transfusion in Cancer Patients Status COMPLETED Phase PHASE3